overcast
Geneva – The World Health Organization insisted on Friday that it would never pass a vaccine that has not proved effective, amid considerations of the rush to expand a VACCINE for COVID-19.
Governments around the world expect to deploy a vaccine against the virus as soon as possible, which has inflamed more than 26 million people, killed thousands of people, shaken millions of lives and wreaked havoc on the global economy.
In general procedures, verification managers will have to wait months or years to ensure that candidate vaccines are effective.
But as the pandemic continues to wreak havoc, there has been a lot of tension in implementing a vaccine, leading to fears that the test criteria will be reduced.
WHO leader Tedros Adhanom Ghebreyesus insisted this is not the case.
“WHO will approve a vaccine that is neither effective nor safe,” he said at a virtual briefing.
He defied the so-called anti-vax movement that has stoked fears about the onset of vaccines.
They could be to “build stories to fight vaccines, but the vaccine record tells its own story,” he said.
Lately, more than 30 human candidate vaccines are being tested, adding at least 8 in final Phase III trials involving tens of thousands of people.
“This is a very positive situation because there is a wide range of candidates,” WHO Chief Scientist Soumya Swaminathan said at Friday’s briefing, noting that about 10% of candidate vaccines are successful.
He explained that “the unprecedented rate of progression of Covid vaccines” was made largely imaginable through past investments in vaccine platforms for other diseases, which had been repurposed for use opposite the novel coronavirus.
But she is under pressure that developers deserve not to skip the rigorous testing stages.
“No vaccine will be deployed en masse until regulators are confident and governments are confident and WHO is confident that these vaccines have met minimum standards of protection and efficacy. “
Tedros expressed the hope that one of them would soon be available “so that the global can return to the norm. “
But while WHO said it hopes to see the effects of a series of Phase III trials through the end of the year, Friday softened hopes that a vaccine will be imminent.
Underscoring the main challenge of making and implementing vaccines for the billions of people around the world who want them, widespread immunization is not expected to begin until mid-2021.
Tedros under pressure that, at least first, the source would be limited.
“Priority will have to be given to the vaccination of essential staff and those most at risk,” he said, stressing that “the first priority will have to be to vaccinate others in all countries than all other people in some countries. “Countries.
WHO has established a mechanism, known as Covax, to ensure a more equitable distribution of all vaccines in the long term, but so far it has struggled to increase the budget to meet the wishes of the 92 poor countries that signed up.
But Tedros said Friday that 78 high- and middle-income countries and economies have already shown their participation, Germany, Japan, Norway and the European Commission last week.
He predicted that in an interconnected world, “the virus will continue to kill and the global economic recovery will be delayed” if the poorest countries are unable to get a vaccine.
Sharing equitably, he said, “is just an ethical imperative and a public imperative of suitability, it is also an economic imperative. “
Since the early stages of the COVID-19 crisis, the Japan Times has provided free access to very important data on the effect of the new coronavirus, as well as practical data on how to deal with the pandemic. today so that we can continue to provide you with up-to-date and detailed data on Japan.
The Japan Times LTD. All rights reserved.